BSX - Boston Scientific Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 558.97B
Enterprise Value 368.11B
Trailing P/E 33.13
Forward P/E 123.69
PEG Ratio (5 yr expected) 12.37
Price/Sales (ttm)5.93
Price/Book (mrq)6.39
Enterprise Value/Revenue 36.85
Enterprise Value/EBITDA 625.71

Trading Information

Stock Price History

Beta (3Y Monthly) 0.71
52-Week Change 327.45%
S&P500 52-Week Change 37.70%
52 Week High 343.66
52 Week Low 331.56
50-Day Moving Average 341.17
200-Day Moving Average 338.55

Share Statistics

Avg Vol (3 month) 38.35M
Avg Vol (10 day) 36.09M
Shares Outstanding 51.39B
Float 1.39B
% Held by Insiders 10.25%
% Held by Institutions 193.40%
Shares Short (Jun 28, 2019) 413.63M
Short Ratio (Jun 28, 2019) 41.7
Short % of Float (Jun 28, 2019) 41.10%
Short % of Shares Outstanding (Jun 28, 2019) 40.98%
Shares Short (prior month May 31, 2019) 414.6M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Nov 6, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 18.08%
Operating Margin (ttm)17.46%

Management Effectiveness

Return on Assets (ttm)5.04%
Return on Equity (ttm)22.10%

Income Statement

Revenue (ttm)9.94B
Revenue Per Share (ttm)7.18
Quarterly Revenue Growth (yoy)4.80%
Gross Profit (ttm)6.99B
EBITDA 2.65B
Net Income Avi to Common (ttm)1.8B
Diluted EPS (ttm)1.28
Quarterly Earnings Growth (yoy)42.30%

Balance Sheet

Total Cash (mrq)139M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)9.49B
Total Debt/Equity (mrq)102.83
Current Ratio (mrq)1.39
Book Value Per Share (mrq)6.64

Cash Flow Statement

Operating Cash Flow (ttm)467M
Levered Free Cash Flow (ttm)-1.9B